| Product Code: ETC070064 | Publication Date: Jul 2023 | Updated Date: Jun 2026 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The Thailand Biobanking Market was estimated at USD 106 Million in 2025 and is projected to reach USD 121 Million by 2032, growing at a CAGR of 1.9% from 2026 to 2032. This steady growth trajectory can be attributed to the increasing demand for biological samples spurred by the prevalence of chronic diseases and a supportive regulatory environment that encourages biomedical research. Moreover, the advancements in automation and digital technologies are enhancing biobanking capabilities, thereby expanding their utility across research and clinical applications.
The Thailand biobanking market exhibited an initial contraction of 3.8% in 2021, attributed to pandemic-induced disruptions and shifts in healthcare priorities. However, the sector rebounded to 2.2% growth in 2022, driven by increasing investments in healthcare infrastructure and a rising demand for personalized medicine. Following this trend, growth accelerated to 2.9% in 2023 and continued on an upward trajectory, reaching 3.1% in 2024 and 3.6% in 2025. This expansion can be traced to advancements in biotechnological methods and heightened awareness of biobanking's role in research and patient care. Consumer demand and government policies promoting health innovation further support sustainable progress, suggesting a strong future through 2032.
This graph highlights how the Thailand Biobanking Market has steadily grown over the past five years, supported by major growth factors.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate | Major Drivers |
| 2021 | -3.8% | Expansion of transportation and logistics networks |
| 2022 | 2.2% | Expansion of commercial construction activities |
| 2023 | 2.9% | Growing urbanization and commercial development |
| 2024 | 3.1% | Government infrastructure modernization initiatives |
| 2025 | 3.6% | Increasing industrial infrastructure investments |
| 2026 | 2.8% | Rising electricity demand across industries |
| 2027 | 2.3% | Growing renewable energy integration projects |
| 2028 | 3.1% | Rising electricity demand across industries |
| 2029 | 3.0% | Increasing adoption of advanced technologies |
| 2030 | 3.1% | Growing renewable energy integration projects |
| 2031 | 3.0% | Rising electricity demand across industries |
| 2032 | 3.1% | Expansion of transportation and logistics networks |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch’s advanced forecasting approach, validated with industry datasets as of June 2026.
The need for well-organized biobanks in Thailand is underscored by the rising incidence of chronic and genetic disorders, which necessitate extensive biological repositories for effective research. This growth is significantly influenced by collaborative initiatives between academic institutions and pharmaceutical companies aiming to harness biological data for innovative treatments.
Furthermore, the national emphasis on personalized medicine has led to an increased focus on biobanking as a critical resource for understanding disease mechanisms. As researchers pursue targeted therapies, the relevance of biobanks in clinical studies and trials becomes increasingly apparent, ensuring their role in the future of healthcare innovation in Thailand.
While the biobanking market in Thailand is on a growth trajectory, it encounters several restraints that may impede its full potential. Ethical considerations surrounding donor consent and data privacy remain paramount, as researchers must navigate complex legal landscapes to maintain public trust. Additionally, the long-term storage of biological samples presents challenges in ensuring their quality and integrity over time. Smaller institutions may also grapple with limited resources, which could hinder their ability to establish robust biobanking operations and collaborate effectively in the research landscape.
Currently, the Thailand biobanking market is experiencing significant trends that are shaping its future. Notably, the integration of digital platforms for data management is becoming increasingly prevalent, allowing for more streamlined access to biobank resources. Additionally, collaborations focused on genomic research are gaining momentum, given the insights they can provide into population health. The pandemic has also accelerated the trend toward remote sample collection and analysis, offering innovative solutions for ongoing research.
As the biobanking market evolves, opportunities for growth are becoming increasingly evident. There is a significant potential for investment in advanced biobanking technologies, particularly those that enhance sample tracking and data integration. Furthermore, developing partnerships with international research organizations presents avenues for knowledge exchange and resource sharing. The rising focus on personalized medicine provides fertile ground for biobanks to align with therapeutic innovations, ultimately benefiting patient care.
The Thai government is actively fostering a supportive environment for biobanking through various initiatives and funding programs aimed at enhancing biomedical research capabilities. Public investments are directed toward establishing and maintaining biobanks, ensuring alignment with global research standards. Moreover, policies encouraging collaborations among universities, research centers, and private sectors are paving the way for innovations in biobanking, ultimately enhancing Thailand’s position in the global scientific community.
Looking ahead to 2026-2032, the Thailand biobanking market is poised for continued evolution as it adapts to emerging scientific advancements and changing healthcare demands. The ongoing emphasis on personalized medicine will likely drive further investments into biobanks, particularly for genetic and genomic research. Additionally, advancements in biotechnology may lead to the development of more sophisticated biobanking infrastructures, enhancing sample preservation and analysis capabilities. As researchers and institutions capitalize on these developments, the role of biobanks as integral components of health innovation will only intensify.
In recent months, the Thailand biobanking landscape has seen several notable developments, particularly in terms of technological advancements aimed at improving sample management. The increasing integration of artificial intelligence and machine learning into biobanking processes is becoming a focus, enhancing data analysis and sample tracking efficiency. Furthermore, collaborations between local institutions and international research networks are being established, fostering knowledge exchange and expanding the reach of Thailand's biobanking capabilities.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Biobanking Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Biobanking Market Revenues & Volume, 2022 & 2032F |
3.3 Thailand Biobanking Market - Industry Life Cycle |
3.4 Thailand Biobanking Market - Porter's Five Forces |
3.5 Thailand Biobanking Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 Thailand Biobanking Market Revenues & Volume Share, By Applications, 2022 & 2032F |
3.7 Thailand Biobanking Market Revenues & Volume Share, By Sample Type, 2022 & 2032F |
4 Thailand Biobanking Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Thailand Biobanking Market Trends |
6 Thailand Biobanking Market, By Types |
6.1 Thailand Biobanking Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Thailand Biobanking Market Revenues & Volume, By Type, 2022-2032F |
6.1.3 Thailand Biobanking Market Revenues & Volume, By Equipment, 2022-2032F |
6.1.4 Thailand Biobanking Market Revenues & Volume, By Consumables, 2022-2032F |
6.1.5 Thailand Biobanking Market Revenues & Volume, By Services, 2022-2032F |
6.1.6 Thailand Biobanking Market Revenues & Volume, By Software, 2022-2032F |
6.2 Thailand Biobanking Market, By Applications |
6.2.1 Overview and Analysis |
6.2.2 Thailand Biobanking Market Revenues & Volume, By Regenerative Medicine, 2022-2032F |
6.2.3 Thailand Biobanking Market Revenues & Volume, By Life Science Research, 2022-2032F |
6.2.4 Thailand Biobanking Market Revenues & Volume, By Clinical Research, 2022-2032F |
6.3 Thailand Biobanking Market, By Sample Type |
6.3.1 Overview and Analysis |
6.3.2 Thailand Biobanking Market Revenues & Volume, By Blood Products, 2022-2032F |
6.3.3 Thailand Biobanking Market Revenues & Volume, By Human Tissues, 2022-2032F |
6.3.4 Thailand Biobanking Market Revenues & Volume, By Nucleic Acids, 2022-2032F |
6.3.5 Thailand Biobanking Market Revenues & Volume, By Cell Lines, 2022-2032F |
6.3.6 Thailand Biobanking Market Revenues & Volume, By Biological Fluids, 2022-2032F |
6.3.7 Thailand Biobanking Market Revenues & Volume, By Human Waste Products, 2022-2032F |
7 Thailand Biobanking Market Import-Export Trade Statistics |
7.1 Thailand Biobanking Market Export to Major Countries |
7.2 Thailand Biobanking Market Imports from Major Countries |
8 Thailand Biobanking Market Key Performance Indicators |
9 Thailand Biobanking Market - Opportunity Assessment |
9.1 Thailand Biobanking Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 Thailand Biobanking Market Opportunity Assessment, By Applications, 2022 & 2032F |
9.3 Thailand Biobanking Market Opportunity Assessment, By Sample Type, 2022 & 2032F |
10 Thailand Biobanking Market - Competitive Landscape |
10.1 Thailand Biobanking Market Revenue Share, By Companies, 2025 |
10.2 Thailand Biobanking Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here